Insider Transactions in Q1 2025 at Drugs Made In America Acquisition Corp. (DMAA)

DMAA Quotes by TradingView

Insider Transaction List (Q1 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Jan 29 2025
Lynn Stockwell CEO and Executive COB
SELL
Open market or private sale
Indirect
5,698,363 -57.81%
-
Jan 29 2025
Lynn Stockwell CEO and Executive COB
SELL
Other acquisition or disposition
Indirect
400,000 -3.9%
-
Jan 29 2025
Lynn Stockwell CEO and Executive COB
BUY
Open market or private purchase
Indirect
400,000 +97.5%
-
Jan 29 2025
Drugs Made In America Acquisition LLC > 10% Shareholder
SELL
Open market or private sale
Direct
5,698,363 -57.81%
-
Jan 29 2025
Drugs Made In America Acquisition LLC > 10% Shareholder
SELL
Other acquisition or disposition
Direct
400,000 -3.9%
-
Jan 29 2025
Drugs Made In America Acquisition LLC > 10% Shareholder
BUY
Open market or private purchase
Direct
400,000 +3.75%
-
Jan 29 2025
Sridhar G. Prasad Director
BUY
Other acquisition or disposition
Direct
100,000 +50.0%
-
Jan 29 2025
Myron W. Shulgan Director
BUY
Other acquisition or disposition
Direct
100,000 +50.0%
-
Jan 29 2025
Glenn C. Worman CFO
BUY
Other acquisition or disposition
Direct
100,000 +50.0%
-
Jan 29 2025
Catherine Do Director
BUY
Other acquisition or disposition
Direct
100,000 +50.0%
-

Track Institutional and Insider Activities on DMAA

Follow Drugs Made In America Acquisition Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAA shares.

Notify only if

Insider Trading

Get notified when an Drugs Made In America Acquisition Corp. insider buys or sells DMAA shares.

Notify only if

News

Receive news related to Drugs Made In America Acquisition Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMAA